 |
- MR Gerstenblith, AM Goldstein, MA Tucker, MC Fraser (2008), Genetic testing for melanoma predisposition: current challenges. Cancer Nurs 30(6):452-459.
- J Saldanha, M Silvy, N Beaufils, R Arlinghaus, G Barbany, S Branford, JM Cayuela, G Cazzaniga, M Gonzalez, D Grimwade, V Kairisto, K Miyamura, M Lawler, T Lion, E Macintyre, FX Mahon, MC Muller, M Ostergaard, H Pfeifer, G Saglio, C Sawyers, O Spinelli, VH van der Velden, JQ Wang, K Zoi, V Patel, P Phillips, P Matejtschuk, J Gabert (2007). Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements. Leukemia 21(7):1487-1487.
- R Yao & E Schneider (2007), Detection of B- and T-cell-specific gene rearrangements in 13 cell lines and 50 clinical specimens using the BIOMED-2 and the original InVivoScribe primers. Leukemia & Lymphoma 48(4):837-840.
- RL Levine et al. (2007), Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Reviews 7:673-683.
- Z Herceg & P Hainaut (2007), Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis. Mol Oncol 1:26-41.
- O Ikediobi et al (2006), Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol Cancer Ther 5(11):2606-2612.
- K Inokuchi (2006), Chronic Myelogenous Leukemia: from molecular biology to clinical aspects and novel targeted therapies. J Nippon Med Sch 73(4):178-192.
- R Ren (2005), Mechanisms of BCR-ABL in the pathogenesis of Chronic Myelogenous Leukemia. Nat Reviews 5:172-183.
- B Messahel et al. (2005), Clinical features of molecular pathology of solid tumours in childhood. Lancet 6:421-430.
- B Chen et al. (2005), Developing a sustainable process to provide quality control materials for genetic testing. Genet Med 37(10):543-49.
- B Sunar-Reeder, DH Atha, S Aydemir, DJ Reeder, L Tully, AR Khan, CD O’Connell (2004). Use of TP53 reference materials to validate mutations in clinical tissue specimens by single-stranded conformational polymorphism analysis. Mol Diagn 8(2):123-130.
- R Kurzrock et al. (2003), Philadelphia chromosome—positive Leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med 138:819-830.
- JJM van Dongen et al. (2003), Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 17:2257-2317.
- DL Stirewalt & JP Radich (2003), The role of FLT3 in haematopoietic malignancies. Nat Reviews 3:650-665.
- R Yao, SA Rich, & E Schneider (2002), Validation of sixteen Leukemia and Lymphoma cell lines as controls for molecular gene rearrangement assays. Clin Chem 48(8):1344-1351.
- S Pelengaris, M Khan, & G Evan (2002), c-MYC: more than just a matter of life and death. Nat Reviews 2:764-776.
- HG Drexler et al. (2000), Continuous hematopoietic cell lines as model systems for Leukemia-Lymphoma research. Leukemia Res 24:881-911.
- JE Rubnitz & WM Crist (1997), Molecular genetics of childhood cancer: implications for pathogenesis, diagnosis, and treatment. Pediatrics 100:101-108.
This page last reviewed: 08/28/2008
|